The trading price of Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) closed lower on Thursday, March 29, closing at $0.19, -43.10% lower than its previous close.
In examining the 52-week price action we see that the stock hit a 52-week high of $4.00 and a 52-week low of $0.26. Over the past month, the stock has lost -50.29% in value.
Tonix Pharmaceuticals Holding Corp, whose market valuation is $15.03 million at the time of this writing, is expected to release its quarterly earnings report Apr 01, 2024 – Apr 07, 2024. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by -$1.64 per share this quarter, however they have predicted annual earnings per share of -$6.64 for 2023 and -$3.14 for 2024. It means analysts are expecting annual earnings per share growth of 67.50% this year and 52.70% next year.
From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue in 2023 is $7.67 million.
A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Tonix Pharmaceuticals Holding Corp No upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest TNXP has a 50% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.
A quick review shows that TNXP’s price is currently -46.87% off the SMA20 and -45.03% off the SMA50. The RSI metric on the 14-day chart is currently showing 22.07, and weekly volatility stands at 28.94%. When measured over the past 30 days, the indicator reaches 12.74%. Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)’s beta value is currently sitting at 2.27, while the Average True Range indicator is currently displaying 0.04.
To see how Tonix Pharmaceuticals Holding Corp stock has been performing in comparison to its peers in the industry, here are the numbers: TNXP stock’s performance was -43.10% in the latest trading, and -94.78% in the past year.
An evaluation of the daily trading volume of Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) indicates that the 3-month average is 1.46 million. However, this figure has increased over the past 10 days to an average of 4.04 million.
Currently, records show that 80.82 million of the company’s shares remain outstanding. The insiders hold 0.01% of outstanding shares, whereas institutions hold 20.77%. The stats also highlight that short interest as of Mar 15, 2024, stood at 0.97 million shares, resulting in a short ratio of 0.76 at that time. From this, we can conclude that short interest is 1.65% of the company’s total outstanding shares. It is noteworthy that short shares in March were up slightly from the previous month’s figure, which was 0.6 million. However, since the stock’s price has seen -53.85% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
